Design, Synthesis and Anti‐Proliferative Assessment of 4‐Aminoquinoline‐ and 4‐Aminoquinoline‐Benzoxaborole Conjugates
A series of 4-aminoquinoline analogues and 4-aminoquinoline-benzoxaborole conjugates were synthesized and evaluated for their antiproliferative activities against two distinct breast cancer cell lines: MCF-7 (estrogen receptor-positive, ER+) and MDA-MB-231 (triple-negative). Preliminary dose-response assays revealed compound 5e, a 4-aminoquinoline-benzoxaborole conjugate, as the most active compound against MCF-7 cells. Structure-activity relationship (SAR) analysis indicated that the cytotoxic potency of the series increased with the length of the alkyl spacer connecting the pharmacophoric moieties. To assess selectivity, HEK-293 cells were employed as a non-cancerous control line, and most compounds exhibited minimal cytotoxicity, except compound 5d, which showed moderate effects. To gain preliminary structural insights, exploratory molecular docking studies were performed against the ligand-binding domain of estrogen receptor alpha (ERα). This integrated experimental-computational approach highlights the identification of promising preliminary hits. Overall, the findings show that 4-aminoquinoline-benzoxaborole conjugates exhibit antiproliferative activity against breast cancer cells, with greater potency towards MCF-7 cells.
Authors
- Raghu Raj (ORCID: https://orcid.org/0000-0001-8222-1314)
- Mandeep Kaur (ORCID: https://orcid.org/0000-0002-9757-4048)
- Vipan Kumar (ORCID: https://orcid.org/0000-0002-6164-7161)
- Sumit Kumar (ORCID: https://orcid.org/0000-0002-4588-7237)
- Sourav Taru Saha
- Anu Saini
Institutions
- Guru Nanak Dev University (IN)
- University of the Witwatersrand (ZA)
- University of Bergen (NO)
Publication Details
- Journal
- ChemMedChem
- Published
- 2026-11-16
- DOI
- https://doi.org/10.1002/cmdc.70538
- Primary Topic
- Heterocyclic Compound Synthesis and Bioactivity
- Type
- article
- Field-Weighted Citation Impact
- 0.00